Cardisio aims to sharply reduce unnecessary deaths, impaired quality of life, and medical expenses by providing an early heart disease screening to more people, more easily and with more accurate results. With these intentions, we developed Cardisiography, an AI-based 3D-vectorcardiography that allows for easy detection of pathological signs of arterial and structural heart diseases. Our innovative technology is much more exact than conventional first-line diagnostics and reaches a sensitivity of more than 90%. For more information about our product and company, please visit: https://cardis.io